Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Resignation of Director for Any Reason Other than Disagreement with the Company.

On April 16, 2021, Ms. Evelyn D'An formally notified the Board of Directors (the "Board") of Enochian Biosciences Inc. (the "Company") of her decision to resign from the Board and the Audit Committee of the Board, effective immediately, in order to accept an engagement to provide financial advisory services to the Company. Ms. D'An's decision to resign was not the result of any disagreement with the Company on any matters relating to the Company's operations, policies, or practices. Following her resignation, Ms. D'An entered into a consulting agreement with the Company. Ms. D'An joined the Board as an independent director in March, 2018, and the Company is grateful for her diligent service as a director, audit committee financial expert, and Audit Committee Chair. The Company looks forward to Ms. D'An taking on an active consulting role applying her significant corporate governance and financial experience.

As of April 16, 2021, and following Ms. D'An's resignation as Audit Committee Chair, the Audit Committee will be comprised of James Sapirstein, Gregg Alton, and Carol L. Brosgart, M.D., whom the Board recently appointed to serve on the Audit Committee. The Board has appointed Mr. Alton to serve as Audit Committee Chair.





                                       2

© Edgar Online, source Glimpses